Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1057-1068 of 1735 results
Page 89 of 145
Key Publications March 14, 2017

The limited public health impact of 'lifestyle' change.

Am J Med. 2016;129:1236

Wald NJ
Cardiovascular Disease Nutrition Prevention
Key Publications March 13, 2017

Management of type 2 diabetes: the current situation and key opportunities to improve care in the UK.

Diabetes Obes Metab. 2016;18:1157-1166

Bain SC, Feher M, Russell-Jones D, Khunti K
Cardiovascular Disease Diabetes Prevention
Key Publications March 13, 2017

Cardiovascular disease in Europe: epidemiological update 2016.

Eur Heart J. 2016;37:3232-3245

Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M
Cardiovascular Disease Epidemiology Prevention
Key Publications March 8, 2017

Aspirin for primary cardiovascular risk prevention and beyond in diabetes mellitus.

Circulation. 2016;134:1579-1594

Capodanno D, Angiolillo DJ
Cardiovascular Disease Diabetes Prevention
Key Publications March 7, 2017

Nutrition facts panel use is associated with higher diet quality and lower glycated hemoglobin concentrations in US adults with undiagnosed prediabetes.

Am J Clin Nutr. 2016;104:1639-1646

Kollannoor-Samuel G, Shebl FM, Hawley NL, Pérez-Escamilla R
Insulin Resistance Nutrition Prevention
Key Publications March 6, 2017

Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement.

JAMA. 2016;316:1997-2007

US Preventive Services Task Force., Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, Gillman MW, Kemper AR, Krist AH, Kurth AE, Landefeld CS, LeFevre ML, Mangione CM, Phillips WR, Owens DK, Phipps MG, Pignone MP
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications March 6, 2017

Statins for prevention of cardiovascular disease in adults: Evidence report and systematic review for the US Preventive Services Task Force.

JAMA. 2016;316:2008-2024

Chou R, Dana T, Blazina I, Daeges M, Jeanne TL
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications March 3, 2017

Interpretation and use of another statin guideline.

JAMA. 2016;316:1977-1979

Greenland P, Bonow RO
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications March 3, 2017

Statins for primary prevention: The debate is intense, but the data are weak.

JAMA. 2016;316:1979-1981

Redberg RF, Katz MH
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications March 3, 2017

Evolving approaches for statins in primary prevention: Progress, but questions remain.

JAMA. 2016;316:1981-1983

Navar AM, Peterson ED
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications February 27, 2017

Cross-sectional analysis of deprivation and ideal cardiovascular health in the Paris Prospective Study 3.

Heart. 2016;102:1890-1897

Empana JP, Perier MC, Singh-Manoux A, Gaye B, Thomas F, Prugger C, Plichart M, Wiernik E, Guibout C, Lemogne C, Pannier B, Boutouyrie P, Jouven X
Cardiovascular Disease Prevention Sex Differences
Key Publications February 20, 2017

Vitamin D deficiency - Is there really a pandemic?

N Engl J Med. 2016;375:1817-1820

Manson JE, Brannon PM, Rosen CJ, Taylor CL
Epidemiology Nutrition Prevention
of 145